The use of probiotics for critically ill patients in hospitals

References

• FAO. 2001. Regulatory and clinical aspects of dairy orobiotics. FAO (online).
   Google Scholar
• Liong MT. Safety of probiotics: translocation and infection. Nutr Rev. 2008;66:192–202.
   PubMed Web of Science ®Google Scholar
• Banasaz M, Norin E, Holma R, Midtvedt T. Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol. 2002;68:3031–4.
   PubMed Web of Science ®Google Scholar
• Isakow W, Morrow LE, Kollef MH. Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. Chest. 2007;132:286–94.
   PubMed Web of Science ®Google Scholar
• Harty DW, Patrikakis M, Hume EB, Oakey HJ, Knox KW. The aggregation of human platelets by Lactobacillus species. J Gen Microbiol. 1993;139:2945–51.
   Google Scholar
• Harty DW, Oakey HJ, Patrikakis M, Hume EB, Knox KW. Pathogenic potential of lactobacilli. Int J Food Microbiol. 1994;24:179–89.
   PubMed Web of Science ®Google Scholar
• Salvana EM, Frank M. Lactobacillus endocarditis: case report and review of cases reported since 1992. J Infect. 2006;53:e5–10.
   PubMedGoogle Scholar
• Abgrall S, Joly V, Derkinderen P, Decre D, Carbon C, Yeni P. Lactobacillus casei infection in an AIDS patient. Eur J Clin Microbiol Infect Dis. 1997;16:180–2.
   PubMed Web of Science ®Google Scholar
• Jones SD, Fullerton DA, Zamora MR, Badesch DB, Campbell DN, Grover FL. Transmission of Lactobacillus pneumonia by a transplanted lung. Ann Thorac Surg. 1994;58:887–9.
   Web of Science ®Google Scholar
• Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrup DM, Keating MR. Lactobacillemia in liver transplant patients. Clin Infect Dis. 1994;18:207–12.
   PubMed Web of Science ®Google Scholar
• Woods GC, Boucher BA, Gorce MA, Fabian TC. Lactobacillus species as a cause of ventilator-associated pneumonia in a critically ill trauma patient. Pharmacotherapy. 2002;22:1180–2.
   Web of Science ®Google Scholar
• Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin Infect Dis. 1997;25:1048–55.
   PubMed Web of Science ®Google Scholar
• Munoz P, Bouza E, Cuenca-Estrella M, Eiros JM, Perez MJ, Sanchez-Somolinos M, . Saccharomyces cerevisiae fungemia: an emerging infectious disease. Clin Infect Dis. 2005;40:1625–34.
   PubMed Web of Science ®Google Scholar
• Lherm T, Monet C, Nougiere B, Soulier M, Larbi D, Le Gall C, . Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med. 2002;28:797–801.
   PubMed Web of Science ®Google Scholar
• Lolis N, Veldekis D, Moraitou H, Kanavaki S, Velegraki A, Triandafyllidis C, . Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit Care. 2008;12:414.
   PubMed Web of Science ®Google Scholar
• Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, . Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 2004;38:62–9.
   PubMed Web of Science ®Google Scholar
• Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, . Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis. 2006;42:e35–44.
   Web of Science ®Google Scholar
• Plummer C, Douglas CW. Relationship between the ability of oral streptococci to interact with platelet glycoprotein Ibalpha and with the salivary low-molecular-weight mucin, MG2. FEMS Immunol Med Microbiol. 2006;48:390–9.
   PubMed Web of Science ®Google Scholar
• Zhou JS, Rutherfurd KJ, Gill HS. Inability of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 to induce human platelet aggregation in vitro. J Food Prot. 2005;68:2459–64.
   Web of Science ®Google Scholar
• Floch MH. Bile salts, intestinal microflora and enterohepatic circulation. Dig Liver Dis. 2002;34(Suppl 2):S54–7.
   Google Scholar
• Midtvedt T. Microbial bile acid transformation. Am J Clin Nutr. 1974;27:1341–7.
   PubMed Web of Science ®Google Scholar
• Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, . In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr. 2001;73:386S–92S.
   PubMed Web of Science ®Google Scholar
• Barrett TD, Yan W, Freedman JM, Lagaud GJ, Breitenbucher JG, Shankley NP. Role of CCK and potential utility of CCK1 receptor antagonism in the treatment of pancreatitis induced by biliary tract obstruction. Br J Pharmacol. 2008;153:1650–8.
   Web of Science ®Google Scholar
• Samuel I, Toriumi Y, Zaheer A, Joehl RJ. Mechanism of acute pancreatitis exacerbation by enteral bile-pancreatic juice exclusion. Pancreatology. 2004;4:527–32.
   Web of Science ®Google Scholar
• Alm L, Leijonmarck C-E, Persson A-K, Midtvedt T. Survival of Lactobacilli during digestion: an in vitro and in vivo study. Grubb R, Midtvedt T, Norin E. The regulatory and protective role of the normal microflora. London: Macmillan Press Ltd. 1989. 293–7.
   Google Scholar
• Franchini M, Zaffanello M, Veneri D. Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Res. 2006;118:177–84.
   PubMed Web of Science ®Google Scholar
• Meyer-Hoffert U, Hornef MW, Henriques-Normark B, Axelsson LG, Midtvedt T, Putsep K, . Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut. 2008;57:764–71.
   PubMed Web of Science ®Google Scholar
• Mater DD, Langella P, Corthier G, Flores MJ. A probiotic Lactobacillus strain can acquire vancomycin resistance during digestive transit in mice. J Mol Microbiol Biotechnol. 2008;14:123–7.
   PubMed Web of Science ®Google Scholar
• Mater DD, Langella P, Corthier G, Flores MJ. Evidence of vancomycin resistance gene transfer between enterococci of human origin in the gut of mice harbouring human micro-biota. J Antimicrob Chemother. 2005;56:975–8.
   PubMed Web of Science ®Google Scholar
• Ammor MS, Florez AB, Mayo B. Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. Food Microbiol. 2007;24:559–70.
   PubMed Web of Science ®Google Scholar
• Florez AB, Ammor MS, Delgado S, Mayo B. Molecular analysis of a chromosome-carried erm(B) gene and its flanking insertion points in Lactobacillus johnsonii G41. Antimicrob Agents Chemother. 2006;50:4189–90.
   Web of Science ®Google Scholar
• Ammor MS, Florez AB, Alvarez-Martin P, Margolles A, Mayo B. Analysis of tetracycline resistance tet(W) genes and their flanking sequences in intestinal Bifidobacterium species. J Antimicrob Chemother. 2008;62:688–93.
   Web of Science ®Google Scholar
• Ammor MS, Florez AB, van Hoek AH, de Los Reyes-Gavilan CG, Aarts HJ, Margolles A, . Molecular characterization of intrinsic and acquired antibiotic resistance in lactic acid bacteria and bifidobacteria. J Mol Microbiol Biotechnol. 2008;14:6–15.
   PubMed Web of Science ®Google Scholar
• Alvarez-Martin P, Florez AB, Mayo B. Screening for plasmids among human bifidobacteria species: sequencing and analysis of pBC1 from Bifidobacterium catenulatum L48. Plasmid. 2007;57:165–74.
   Web of Science ®Google Scholar
• Florez AB, Ammor MS, Mayo B. Identification of tet(M) in two Lactococcus lactis strains isolated from a Spanish traditional starter-free cheese made of raw milk and conjugative transfer of tetracycline resistance to lactococci and enterococci. Int J Food Microbiol. 2008;121:189–94.
   Web of Science ®Google Scholar
• Gould K, Short G. Probiotics and antibiotic-associated diarrhoea – a logical flaw? J Antimicrob Chemother. 2008;61:761.
   Web of Science ®Google Scholar
• Bengmark S. Progress in perioperative enteral tube feeding. Clin Nutr. 1998;17:145–52.
   PubMed Web of Science ®Google Scholar
• Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361:512–9.
   PubMed Web of Science ®Google Scholar
• Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics – approaching a definition. Am J Clin Nutr. 2001;73:361S–4S.
   PubMed Web of Science ®Google Scholar
• Pineiro M, Asp N-G, Reid G, Macfarlane S, Morelli L, Brunser O, . FAO technical meeting on prebiotics. J Clin Gastroenterol. 2008;42:S156–9.
   PubMed Web of Science ®Google Scholar
• Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, . Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation – a randomized, double-blind trial. Am J Transplant. 2005;5:125–30.
   PubMed Web of Science ®Google Scholar
• Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nussler NC, . Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg. 2007;246:36–41.
   PubMed Web of Science ®Google Scholar
• Olah A, Belagyi T, Poto L, Romics L Jr, Bengmark S. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Hepatogastroenterology. 2007;54:590–4.
   PubMed Web of Science ®Google Scholar
• Olah A, Belagyi T, Issekutz A, Gamal ME, Bengmark S. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg. 2002;89:1103–7.
   PubMed Web of Science ®Google Scholar
• van Santvoort HC, Besselink MG, Timmerman HM, van Minnen LP, Akkermans LM, Gooszen HG. Probiotics in surgery. Surgery. 2008;143:1–7.
   Web of Science ®Google Scholar
• Xu T, Cai Q. Prophylactic antibiotic treatment in acute necrotizing pancreatitis: results from a meta-analysis. Scand J Gastroenterol. 2008;43:1249–58.
   PubMed Web of Science ®Google Scholar
• Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, . Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371:651–9.
   PubMed Web of Science ®Google Scholar
• Sand J, Nordback I. Probiotics in severe acute pancreatitis. Lancet. 2008;371:634–5.
   Web of Science ®Google Scholar
• Soeters PB. Probiotics: did we go wrong, and if so, where? Clin Nutr. 2008;27:173–8.
   PubMed Web of Science ®Google Scholar
• Pillai A, Nelson R. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database syst Rev. 2008;23.
   Web of Science ®Google Scholar
• Surawicz CM. Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol. 2008;42(Suppl 2):S64–70.
   Web of Science ®Google Scholar
• Doron SI, Hibberd PL, Gorbach SL. Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol. 2008;42(Suppl 2):S58–63.
   Web of Science ®Google Scholar
• Doron SI, Hibberd PL, Gorbach SL. Probiotics for prevention of antibiotic-associated diarrhea. J Clin Gastroenterol. 2008;42(Suppl 2):S58–63.
   Web of Science ®Google Scholar
• Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res. 1992;32:141–4.
   PubMed Web of Science ®Google Scholar
• Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral D x RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine. 1995;13:310–12.
   PubMed Web of Science ®Google Scholar
• Wenus C, Goll R, Loken EB, Biong AS, Halvorsen DS, Florholmen J. Prevention of antibiotic-associated diarrhoea by a fermented probiotic milk drink. Eur J Clin Nutr. 2008;62:299–301.
   PubMed Web of Science ®Google Scholar
• Katz JA. Probiotics for the prevention of antibiotic-associated diarrhea and Clostridium difficile diarrhea. J Clin Gastroenterol. 2006;40:249–55.
   Web of Science ®Google Scholar
• Wiesen P, Van Gossum A, Preiser JC. Diarrhoea in the critically ill. Curr Opin Crit Care. 2006;12:149–54.
   PubMed Web of Science ®Google Scholar
• Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet. 2007;369:1614–20.
   PubMed Web of Science ®Google Scholar
• Honeycutt TC, El Khashab M, Wardrop RM III, McNeal-Trice K, Honeycutt AL, Christy CG, . Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: a randomized placebo-controlled trial. Pediatr Crit Care Med. 2007;8:452–8.
   PubMed Web of Science ®Google Scholar
• Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2006;CD004826.
   PubMed Web of Science ®Google Scholar
• Ewaschuk JB, Tejpar QZ, Soo I, Madsen K, Fedorak RN. The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. Curr Gastroenterol Rep. 2006;8:486–98.
   PubMedGoogle Scholar
• Seksik P, Sokol H, Lepage P, Vasquez N, Manichanh C, Mangin I, . Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther. 2006;24(Suppl 3):11–8.
   Web of Science ®Google Scholar
• Subramanian S, Campbell BJ, Rhodes JM. Bacteria in the pathogenesis of inflammatory bowel disease. Curr Opin Infect Dis. 2006;19:475–84.
   PubMed Web of Science ®Google Scholar
• Jones JL, Foxx-Orenstein AE. The role of probiotics in inflammatory bowel disease. Dig Dis Sci. 2007;52:607–11.
   PubMed Web of Science ®Google Scholar
• Froehlich F, Juillerat P, Pittet V, Felley C, Mottet C, Vader JP, . Maintenance of surgically induced remission of Crohn's disease. Digestion. 2007;76:130–5.
   PubMed Web of Science ®Google Scholar
• Van Gossum A, Dewit O, Louis E, de Hertogh G, Baert F, Fontaine F, . Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after ileo-caecal resection. Inflamm Bowel Dis. 2007;13:135–42.
   PubMed Web of Science ®Google Scholar
• Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, . Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut. 2004;53:1617–23.
   PubMed Web of Science ®Google Scholar
• Gotteland M, Brunser O, Cruchet S. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther. 2006;23:1077–86.
   PubMed Web of Science ®Google Scholar
• Park SK, Park DI, Choi JS, Kang MS, Park JH, Kim HJ, . The effect of probiotics on Helicobacter pylori eradication. Hepatogastroenterology. 2007;54:2032–6.
   PubMed Web of Science ®Google Scholar
• Ledoux D, Labombardi VJ, Karter D. Lactobacillus acidophilus bacteraemia after use of a probiotic in a patient with AIDS and Hodgkin's disease. Int J STD AIDS. 2006;17:280–2.
   PubMed Web of Science ®Google Scholar
• Quigley EM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130:S78–90.
   PubMed Web of Science ®Google Scholar
• Blahova K. (Hemolytic-uremic syndrome.) Vnitr Lek. 2004; 50:519–25 (in Czech).
   Google Scholar